Arcadia Biosciences (RKDA) Gross Profit (2016 - 2025)
Arcadia Biosciences filings provide 12 years of Gross Profit readings, the most recent being $192000.0 for Q4 2025.
- On a quarterly basis, Gross Profit fell 50.64% to $192000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 15.55% decrease, with the full-year FY2025 number at $1.8 million, down 15.47% from a year prior.
- Gross Profit hit $192000.0 in Q4 2025 for Arcadia Biosciences, down from $418000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $835.4 million in Q2 2021 to a low of -$6.7 million in Q4 2022.
- Median Gross Profit over the past 5 years was $492500.0 (2023), compared with a mean of $41.8 million.
- Biggest five-year swings in Gross Profit: soared 69199.5% in 2021 and later plummeted 1329.3% in 2022.
- Arcadia Biosciences' Gross Profit stood at $546000.0 in 2021, then plummeted by 1329.3% to -$6.7 million in 2022, then surged by 108.92% to $599000.0 in 2023, then tumbled by 35.06% to $389000.0 in 2024, then tumbled by 50.64% to $192000.0 in 2025.
- The last three reported values for Gross Profit were $192000.0 (Q4 2025), $418000.0 (Q3 2025), and $631000.0 (Q2 2025) per Business Quant data.